Literature DB >> 11880429

Detection of heat-stable antigens of Campylobacter jejuni and C. coli by direct agglutination and passive hemagglutination.

A N Oza1, R T Thwaites, D R A Wareing, F J Bolton, J A Frost.   

Abstract

The two serotyping schemes for the detection of heat-stable antigens of Campylobacter jejuni and Campylobacter coli use the same strains for antiserum production but differ in the detection systems used for identifying agglutination. The Penner method uses passive hemagglutination (PHA) while the Laboratory of Enteric Pathogens method uses the same antisera but in a whole-bacterial-cell direct agglutination (DA) protocol. C. jejuni produces a polysaccharide capsule, which is antigenic, and is the main component detected by the PHA method. The DA method will detect both capsule antigens and lipopolysaccharide (LPS) or lipooligosaccharide (LOS) surface antigens. Comparison of both methods by using a selection of isolates from human infection has shown a range of variation in agglutination specificity, reflecting the differences in antigens detected by the two methods. While 27.4% of the 416 C. jejuni isolates reacted with the antisera raised against the same type strains by either method, the majority showed a range of more complex relationships. None of the 37 C. coli isolates reacted with the same antiserum by both methods. Together the two schemes gave a total of 102 distinct combined serogroups for C. jejuni and 16 for C. coli. Thus, while some clonally related isolates share the same capsule and LOS or LPS antigens, other strains appear to have a common capsule antigen but differ in their LPS or LOS structures or vice versa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880429      PMCID: PMC120255          DOI: 10.1128/JCM.40.3.996-1000.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Coinfection with Campylobacter species: an epidemiological problem?

Authors:  J F Richardson; J A Frost; J M Kramer; R T Thwaites; F J Bolton; D R Wareing; J A Gordon
Journal:  J Appl Microbiol       Date:  2001-08       Impact factor: 3.772

2.  Serological analysis of the heat-stable antigens involved in serotyping Campylobacter jejuni and Campylobacter coli.

Authors:  A P Moran; T U Kosunen
Journal:  APMIS       Date:  1989-03       Impact factor: 3.205

3.  Genome sequence-based fluorescent amplified fragment length polymorphism of Campylobacter jejuni, its relationship to serotyping, and its implications for epidemiological analysis.

Authors:  M Desai; J M Logan; J A Frost; J Stanley
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens.

Authors:  J L Penner; J N Hennessy
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

5.  Campylobacter contamination of raw meat and poultry at retail sale: identification of multiple types and comparison with isolates from human infection.

Authors:  J M Kramer; J A Frost; F J Bolton; D R Wareing
Journal:  J Food Prot       Date:  2000-12       Impact factor: 2.077

6.  Multilocus sequence typing system for Campylobacter jejuni.

Authors:  K E Dingle; F M Colles; D R Wareing; R Ure; A J Fox; F E Bolton; H J Bootsma; R J Willems; R Urwin; M C Maiden
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors.

Authors:  H Lior; D L Woodward; J A Edgar; L J Laroche; P Gill
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

8.  Structural and antigenic properties of lipopolysaccharides from serotype reference strains of Campylobacter jejuni.

Authors:  M A Preston; J L Penner
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

9.  Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains.

Authors:  C M Patton; I K Wachsmuth; G M Evins; J A Kiehlbauch; B D Plikaytis; N Troup; L Tompkins; H Lior
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

10.  Structural and antigenic heterogeneity of lipopolysaccharides of Campylobacter jejuni and Campylobacter coli.

Authors:  S M Logan; T J Trust
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

View more
  7 in total

1.  Molecular typing of Campylobacter jejuni and Campylobacter coli.

Authors:  Albert J Lastovica
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Sources of Campylobacter spp. colonizing housed broiler flocks during rearing.

Authors:  S A Bull; V M Allen; G Domingue; F Jørgensen; J A Frost; R Ure; R Whyte; D Tinker; J E L Corry; J Gillard-King; T J Humphrey
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

3.  Specific detection of Campylobacter jejuni from faeces using single nucleotide polymorphisms.

Authors:  E L Best; A J Fox; R J Owen; J Cheesbrough; F J Bolton
Journal:  Epidemiol Infect       Date:  2006-11-17       Impact factor: 2.451

4.  Comparative typing of Campylobacter jejuni by heat-stable serotyping and PCR-based restriction fragment length polymorphism analysis.

Authors:  Ulla-Maija Nakari; Katja Laaksonen; Maija Korkeila; Anja Siitonen
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

Review 5.  Global Distribution of Campylobacter jejuni Penner Serotypes: A Systematic Review.

Authors:  Brian L Pike; Patricia Guerry; Frédéric Poly
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

6.  Comparison of Antimicrobial Susceptibility of Campylobacter Strains Isolated from Food Samples and Patients with Diarrhea.

Authors:  Bita Bakhshi; Amin Naseri; Masoud Alebouyeh
Journal:  Iran Biomed J       Date:  2015-11-25

Review 7.  Campylobacter polysaccharide capsules: virulence and vaccines.

Authors:  Patricia Guerry; Frédéric Poly; Mark Riddle; Alexander C Maue; Yu-Han Chen; Mario A Monteiro
Journal:  Front Cell Infect Microbiol       Date:  2012-02-15       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.